Oncology and Hematology
Episodes 17-32 of 116
John Mascarenhas, MD
Gabriela Hobbs, MD
John Mascarenhas, MD
Gabriela Hobbs, MD
Gabriela Hobbs, MD
John Mascarenhas, MD
Gabriela Hobbs, MD
John Mascarenhas, MD
John Mascarenhas, MD
Aiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
- MinuteCE®
Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC
1.00 program creditAiwu Ruth He, MD, PhD
Aiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
- MinuteCE®
Use of ICI Combination Regimens in Patients With Intermediate-Stage HCC
1.00 program creditGhassan K. Abou-Alfa, MD